However, it is notable that both iCAFs and myCAFs expressed profoundly more CCL2 cytokine than other cell populations from PDA tumors (Figure 3, F–H, and Supplemental Figure 2D), suggesting they both have a robust capacity to recruit monocytes via CCL2. The gene discussed is CCL2; the disease is Patent ductus arteriosus.